Your session is about to expire
← Back to Search
Inhaled Isopropyl Alcohol vs Eucalyptus for Migraine-Related Nausea
Study Summary
This trial is testing if breathing in isopropyl alcohol can relieve nausea from migraines better than a placebo.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 65 years old and get migraines with nausea at least twice a month.I have not been diagnosed with acute migraines.I am younger than 18 or older than 65.
- Group 1: Isopropyl Alcohol Vapors
- Group 2: Eucalyptus Oil Scent
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the enrolment rate for this clinical research?
"Affirmative. Clinicaltrials.gov details that this clinical trial, initially posted on November 11th 2021 is actively seeking participants. 50 patients need to be enrolled at a single medical centre."
Does this research involve any participants aged eighty or above?
"According to the trial's eligibility criteria, applicants between 18 and 65 are qualified for this investigation. Notably, there are 43 studies available specifically for minors, while 171 trials target patients who have surpassed 65 years old."
Are there still available slots in this clinical research project?
"Per the details provided on clinicaltrials.gov, this research study is actively seeking participants. It was initially shared to the public domain on November 11th 2021 and has since been refreshed on December 27th of that same year."
Am I eligible to participate in this research venture?
"This research endeavour is accepting 50 people with migraine between 18 and 65 years old. Applicants must meet the following criteria: Patients aged 18 to 65 who experience nausea associated migraines at least bi-monthly."
Share this study with friends
Copy Link
Messenger